CR10105A - - Google Patents

Info

Publication number
CR10105A
CR10105A CR10105A CR10105A CR10105A CR 10105 A CR10105 A CR 10105A CR 10105 A CR10105 A CR 10105A CR 10105 A CR10105 A CR 10105A CR 10105 A CR10105 A CR 10105A
Authority
CR
Costa Rica
Application number
CR10105A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of CR10105A publication Critical patent/CR10105A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Obesity (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Child & Adolescent Psychology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CR10105A 2005-12-20 2008-06-20 CR10105A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MXPA05014090A MXPA05014090A (es) 2005-12-20 2005-12-20 Composiciones farmaceuticas que comprenden sustancias inhibidoras de las lipasas intestinales combinadas con un complejo o- coordinado de dinicotinato de cromo para su uso en el tratamiento y control de la obesidad o sobrepeso.

Publications (1)

Publication Number Publication Date
CR10105A true CR10105A (pt) 2008-08-06

Family

ID=38188839

Family Applications (1)

Application Number Title Priority Date Filing Date
CR10105A CR10105A (pt) 2005-12-20 2008-06-20

Country Status (6)

Country Link
EP (1) EP1964558A1 (pt)
BR (1) BRPI0620105A2 (pt)
CR (1) CR10105A (pt)
EC (1) ECSP088565A (pt)
MX (1) MXPA05014090A (pt)
WO (1) WO2007073134A1 (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103320755A (zh) 2006-12-13 2013-09-25 出光兴产株式会社 溅射靶及氧化物半导体膜
RU2008106419A (ru) * 2008-02-21 2009-08-27 Закрытое акционерное общество "Ива фарм" (RU) Лекарственные средства на основе олигоядерных координационных соединений d-металлов, способ терапевтического воздействия на организм пациента и способ повышения терапевтической эффективности фармакологически активного вещества

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5612039A (en) * 1994-03-14 1997-03-18 Nini E. Policappelli Dietary supplement
WO2004078113A2 (en) * 2003-03-04 2004-09-16 Pharmacia Corporation Treatment and prevention of obesity with cox-2 inhibitors alone or in combination with weight-loss agents

Also Published As

Publication number Publication date
MXPA05014090A (es) 2007-06-20
BRPI0620105A2 (pt) 2011-11-01
EP1964558A1 (en) 2008-09-03
WO2007073134A1 (es) 2007-06-28
ECSP088565A (es) 2008-07-30

Similar Documents

Publication Publication Date Title
BE2025C533I2 (pt)
BE2023C529I2 (pt)
BE2021C552I2 (pt)
BE2021C531I2 (pt)
BE2021C524I2 (pt)
BE2021C519I2 (pt)
BE2020C531I2 (pt)
BE2020C511I2 (pt)
BE2020C508I2 (pt)
BE2019C521I2 (pt)
BE2019C503I2 (pt)
BE2018C037I2 (pt)
BE2018C035I2 (pt)
BE2018C019I2 (pt)
BE2018C016I2 (pt)
BE2017C028I2 (pt)
BE2019C533I2 (pt)
BE2018C028I2 (pt)
BE2017C007I2 (pt)
BE2016C045I2 (pt)
BE2016C022I2 (pt)
BE2015C074I2 (pt)
BE2014C012I2 (pt)
BE2013C074I2 (pt)
BE2013C014I2 (pt)

Legal Events

Date Code Title Description
FA Abandonment or withdrawal (granting procedure)